[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334658-105":59,"doc-detail-334658-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enhancing-cisplatin-efficacy-with-low-toxicity-in-solid-breast-cancer-cells-using-ph-charge-reversal-sericin-based-nanocarriers-development-characterization-and-in-vitro-biological-assessment","Enhancing Cisplatin Efficacy with Low Toxicity in Solid Breast Cancer Cells Using pH-Charge-Reversal Sericin-Based Nanocarriers: Development, Characterization, and In Vitro Biological Assessment","","Platinum-based chemotherapeutic agents act on DNA, but their lack of selectivity harms normal cells and increases side effects, motivating precise drug-delivery strategies. Nanotechnology offers protein-based nanocarriers as promising systems, with silk sericin nanoparticles highlighted for cancer delivery. This study designs a sericin-based nanocarrier with surface charge reversal to transport cisplatin into MCF-7 breast cancer cells (Cispt-SNC). Molecular docking (AutoDock4.2) identifies key amino acids and conformational clusters supporting drug–protein interactions. Flash nanoprecipitation enables reproducible fabrication and optimization of the carrier material. Dynamic light scattering and SEM assess size, charge, and morphology, while FTIR, circular dichroism, and EDX characterize chemical structure and composition. Optimal conditions yield ~180 nm particles and 84% encapsulation efficiency at 0.1% (w/v) sericin with negative net charge at pH 7.4. In vitro results show pH-dependent stability and release consistent with mildly acidic tumor environments (pH 6.0–7.0), enhanced uptake, and apoptosis indicators including DNA fragmentation and chromatin condensation at pH 6. The study concludes that sericin-based pH-responsive nanocarriers support controlled, tumor-specific cisplatin delivery, improving therapeutic potential while mitigating toxicity concerns.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancing-cisplatin-efficacy-with-low-toxicity-in-solid-breast-cancer-cells-using-ph-charge-reversal-sericin-based-nanocarriers-development-characterization-and-in-vitro-biological-assessment/334658/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancing-cisplatin-efficacy-with-low-toxicity-in-solid-breast-cancer-cells-using-ph-charge-reversal-sericin-based-nanocarriers-development-characterization-and-in-vitro-biological-assessment/334658.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in cisplatin chemotherapy?","Question",{"text":112,"@type":113},"Cisplatin acts broadly on DNA and also affects normal cells, causing significant side effects. The work aims to improve selectivity and enable more controlled delivery to tumor cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the pH-charge-reversal sericin nanocarrier work?",{"text":117,"@type":113},"The sericin-based nanocarrier is engineered for surface charge reversal, supporting cisplatin transport into MCF-7 cells. It also shows pH-dependent stability and drug release aligned with the mildly acidic tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental methods were used to characterize the nanocarriers?",{"text":121,"@type":113},"The study evaluates size, surface charge, and morphology using dynamic light scattering (DLS) and scanning electron microscopy (SEM). Chemical and conformational properties are assessed by FTIR and circular dichroism (CD), and elemental composition is measured using energy-dispersive X-ray spectroscopy (EDX).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334658,1790129556,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","This article is licensed under CC-BY-NC-ND 4.0   \n[http://pubs.acs.org/journal/acsodf](http://pubs.acs.org/journal/acsodf)  Article   \nEnhancing Cisplatin Efficacy with Low Toxicity in Solid Breast Cancer Cells Using pH-Charge-Reversal Sericin-Based Nanocarriers: Development, Characterization, and In Vitro Biological Assessment  \nKiana Bahremand, Faranak Aghaz,* and Kiumars Bahrami *  \n Cite This: ACS Omega 2024, 9, 14017−14032  \nRead Online  \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |\n\nABSTRACT: Platinum-based chemotherapeutic agents are widely employed in cancer treatment because of their effectiveness in targeting DNA. However, this indiscriminate action often affects both cancerous and normal cells, leading to severe side effects and highlighting the need for innovative approaches in achieving precise drug delivery. Nanotechnology presents a promising avenue for addressing these challenges. Protein-based nanocarriers exhibit promising capabilities in the realm of cancer drug delivery with silk sericin nanoparticles standing out as a leading contender. This investigation focuses on creating a sericin-based nanocarrier (SNC) featuring surface charge reversal designed to effectively transport cisplatin (Cispt-SNC) into MCF-7 breast cancer cells. Utilizing AutoDock4.2, our molecular docking analyses identified key amino acids and revealed distinctive conformational clusters, providing insights into the drug−protein interaction landscape and highlighting the potential of sericin as a carrier for controlled drug release. The careful optimization and fabrication of sericin as the carrier material were achieved through flash nanoprecipitation, a straightforward and reproducible method that is devoid of intricate equipment. The physicochemical properties of SNCs and Cispt-SNCs, particularly concerning size, surface charge, and morphology, were evaluated using dynamic light scattering (DLS) and scanning electron microscopy (SEM). Chemical and conformational analyses of the nanocarriers were conducted using Fourier-transform infrared spectroscopy (FTIR) and circular dichroism (CD), and elemental composition analysis was performed through energy-dispersive X-ray spectroscopy (EDX). This approach aimed to achieve the smallest nanoparticle size for Cispt-SNCs (180 nm) and high drug encapsulation efficiency (84%) at an optimal sericin concentration of 0.1%(w/v), maintaining a negative net charge at a physiological pH (7.4). Cellular uptake and cytotoxicity were investigated in MCF-7 breast cancer cells. SNCs demonstrated stability and exhibited a pH-dependent drug release behavior, aligning with the mildly acidic tumor microenvironment (pH 6.0−7.0). Efficient cellular uptake of Cispt-SNC, along with DNA fragmentation and chromatin condensation, was found at pH 6, leading to cell apoptosis. These results collectively indicate the potential of SNCs for achieving controlled drug release in a tumor-specific context. Our in vitro studies reveal the cytotoxicity of both cisplatin and Cispt-SNCs on MCF-7 cells. Cisplatin significantly reduced cell viability at 10 μM concentration (IC50), and the unique combination of sericin and cisplatin showcased enhanced cell viability compared to cisplatin alone, suggesting that controlled drug release is indicated by a gradient decrease in cell viability and highlighting SNCs as promising carriers. The study underscores the promise of protein-based nanocarriers in advancing targeted drug delivery for cancer therapy.  \n■ INTRODUCTION  \nBreast cancer, a prevalent form of cancer, holds the distinguished position of being the most frequently diagnosed malignancy globally, accounting for the highest number of diagnosed cases (2.3 million, 24.5% of all cancers) and cancerrelated deaths (684,996, 15.5% of all cancer deaths) in 2020.1 As a result, the estimated number of newly diagnosed invasive cancer cases among women in the United States in 2023 reveals ","cbCaitRPl0WSSOaS","https://ap.wps.com/l/cbCaitRPl0WSSOaS","pdf",14444253,16,"English","# ABSTRACT\n# INTRODUCTION\n## Breast cancer burden and conventional therapy limitations\n## Cisplatin and challenges in systemic chemotherapy","[{\"question\":\"What problem does the study address in cisplatin chemotherapy?\",\"answer\":\"Cisplatin acts broadly on DNA and also affects normal cells, causing significant side effects. The work aims to improve selectivity and enable more controlled delivery to tumor cells.\"},{\"question\":\"How does the pH-charge-reversal sericin nanocarrier work?\",\"answer\":\"The sericin-based nanocarrier is engineered for surface charge reversal, supporting cisplatin transport into MCF-7 cells. It also shows pH-dependent stability and drug release aligned with the mildly acidic tumor microenvironment.\"},{\"question\":\"What experimental methods were used to characterize the nanocarriers?\",\"answer\":\"The study evaluates size, surface charge, and morphology using dynamic light scattering (DLS) and scanning electron microscopy (SEM). Chemical and conformational properties are assessed by FTIR and circular dichroism (CD), and elemental composition is measured using energy-dispersive X-ray spectroscopy (EDX).\"}]","Enhancing Cisplatin Efficacy with Low Toxicity in Solid Breast Cancer Cells Using pH-Charge-Reversal Sericin-Based Nanocarriers: Development, Characterization, and In Vitro Biological Assessment | PDF",1790007679]